Clinical Trial Update: A Long-Term Study in Schizophrenia [Phase 3]

View source ↗

Summary

A long-term Phase 3 study in schizophrenia sponsored by Eli Lilly has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Snippet

Sponsor: Eli Lilly and Company | Conditions: Schizophrenia | Phase 3 | Status: TERMINATED